Pharmacometrics, Artificial Intelligence, and Machine Learning in Precision Dosing and Clinical Toxicology

Background: Therapeutic drug monitoring (TDM) enables individualized pharmacotherapy for drugs with high interpatient variability and concentration-dependent effects. Conventional Bayesian approaches, although clinically established, may not fully capture pharmacokinetic complexity in dynamic or heterogeneous patient populations. Artificial intelligence (AI) and machine-learning methods offer complementary capabilities, including modeling nonlinear relationships and integrating high-dimensional clinical data. Methods: Peer-reviewed studies that applied AI or machine-learning methods to TDM between January 2017 and April 2026 were reviewed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Studies involving adult and pediatric populations were included, whereas reviews, editorials, and animal studies were excluded. Results: Forty-seven studies covering a range of drugs, including vancomycin, tacrolimus, antiepileptics, mycophenolic acid, methotrexate, and voriconazole, were included. Tree-based ensemble methods, particularly eXtreme Gradient Boosting, random forest, and gradient boosting, were the most frequently applied algorithms. In general, these methods demonstrated strong predictive performance, with area under the receiver operating characteristic curve values up to 0.90 for classification tasks and coefficient of determination values up to 0.85 for regression tasks. In 13 studies, AI models demonstrated predictive performance comparable with or exceeding that of traditional population pharmacokinetic and Bayesian approaches for selected applications. However, these comparisons were heterogeneous and often based on retrospective data sets with limited external validation. Conclusions: AI-based methods have considerable potential for enhancing TDM, particularly for dose optimization, drug-exposure estimation, and toxicity prediction. However, evidence linking improved predictive performance to meaningful clinical outcomes remains limited.

Authors

Publication Details

Journal
Therapeutic Drug Monitoring
Published
2026-11-19
DOI
https://doi.org/10.1097/ftd.0000000000001553
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pharmacometrics, Artificial Intelligence, and Machine Learning in Precision Dosing and Clinical Toxicology

Uwe Christians, Carlos Goncalves, Wanzhu Zhao
Therapeutic Drug Monitoring
Artificial Intelligence in Healthcare and Education
article

Pharmacometrics, Artificial Intelligence, and Machine Learning in Precision Dosing and Clinical Toxicology

Uwe Christians, Carlos Goncalves, Wanzhu Zhao
article en

Abstract

Background: Therapeutic drug monitoring (TDM) enables individualized pharmacotherapy for drugs with high interpatient variability and concentration-dependent effects. Conventional Bayesian approaches, although clinically established, may not fully capture pharmacokinetic complexity in dynamic or heterogeneous patient populations. Artificial intelligence (AI) and machine-learning methods offer complementary capabilities, including modeling nonlinear relationships and integrating high-dimensional clinical data. Methods: Peer-reviewed studies that applied AI or machine-learning methods to TDM between January 2017 and April 2026 were reviewed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines. Studies involving adult and pediatric populations were included, whereas reviews, editorials, and animal studies were excluded. Results: Forty-seven studies covering a range of drugs, including vancomycin, tacrolimus, antiepileptics, mycophenolic acid, methotrexate, and voriconazole, were included. Tree-based ensemble methods, particularly eXtreme Gradient Boosting, random forest, and gradient boosting, were the most frequently applied algorithms. In general, these methods demonstrated strong predictive performance, with area under the receiver operating characteristic curve values up to 0.90 for classification tasks and coefficient of determination values up to 0.85 for regression tasks. In 13 studies, AI models demonstrated predictive performance comparable with or exceeding that of traditional population pharmacokinetic and Bayesian approaches for selected applications. However, these comparisons were heterogeneous and often based on retrospective data sets with limited external validation. Conclusions: AI-based methods have considerable potential for enhancing TDM, particularly for dose optimization, drug-exposure estimation, and toxicity prediction. However, evidence linking improved predictive performance to meaningful clinical outcomes remains limited.

Therapeutic Drug Monitoring
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon